blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1757268

EP1757268 - DRY-FORM COMPOSITION FOR ORAL INGESTION AND GEL-FORM COMPOSITION FOR ORAL INGESTION OF TYPE PREPARED AT TIME OF USE [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  11.05.2018
Database last updated on 07.06.2024
FormerThe patent has been granted
Status updated on  02.06.2017
FormerGrant of patent is intended
Status updated on  13.12.2016
Most recent event   Tooltip26.06.2020Lapse of the patent in a contracting state
New state(s): CY		published on 29.07.2020  [2020/31]
Applicant(s)For all designated states
Kureha Corporation
3-3-2, Nihonbashi-Hamacho, Chuo-ku
Tokyo 103-8552 / JP
[2017/27]
Former [2007/09]For all designated states
Kureha Corporation
3-3-2, Nihonbashi-Hamacho, Chuo-ku
Tokyo 103-8552 / JP
Inventor(s)01 / ISHII, Kazumi, @Kureha Corporation
Biomed. Research Labs.
3-26-2, Hyakunin-cho
Shin
Shinjuku-ku, Tokyo 169-8503 / JP
02 / ONO, Saichi, @Kureha Corporation
Biomed. Research Labs.
3-26-2, Hyakunin-cho
Shin
Shinjuku-ku, Tokyo 169-8503 / JP
03 / CHIBA, Tadahiko, @Kureha Corporation
Biomed. Research Labs.
3-26-2, Hyakunin-cho
Shin
Shinjuku-ku, Tokyo 169-8503 / JP
 [2017/27]
Former [2007/09]01 / ISHII, Kazumi, Kureha Corporation
Biomed. Research Labs., 3-26-2, Hyakunin-cho, Shin
Shinjuku-ku, Tokyo 169-8503 / JP
02 / ONO, Saichi, Kureha Corporation
Biomed. Research Labs., 3-26-2, Hyakunin-cho, Shin
Shinjuku-ku, Tokyo 169-8503 / JP
03 / CHIBA, Tadahiko, Kureha Corporation
Biomed. Research Labs., 3-26-2, Hyakunin-cho, Shin
Shinjuku-ku, Tokyo 169-8503 / JP
Representative(s)BRP Renaud & Partner mbB Rechtsanwälte Patentanwälte Steuerberater
Königstraße 28
70173 Stuttgart / DE
[2017/27]
Former [2008/31]HOFFMANN EITLE
Patent- und Rechtsanwälte Arabellastrasse 4
81925 München / DE
Former [2007/09]HOFFMANN EITLE
Patent- und Rechtsanwälte Arabellastrasse 4
81925 München / DE
Application number, filing date05741450.023.05.2005
[2007/09]
WO2005JP09354
Priority number, dateJP2004016836807.06.2004         Original published format: JP 2004168368
[2007/09]
Filing languageJA
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2005120458
Date:22.12.2005
Language:EN
[2005/51]
Type: A1 Application with search report 
No.:EP1757268
Date:28.02.2007
Language:EN
The application published by WIPO in one of the EPO official languages on 22.12.2005 takes the place of the publication of the European patent application.
[2007/09]
Type: B1 Patent specification 
No.:EP1757268
Date:05.07.2017
Language:EN
[2017/27]
Search report(s)International search report - published on:JP22.12.2005
(Supplementary) European search report - dispatched on:EP09.06.2010
ClassificationIPC:A61K9/06, A23L29/212, A23L29/25
[2017/01]
CPC:
A23K20/163 (EP,US); A61K8/042 (US); A23K50/40 (EP,US);
A23L29/015 (EP,US); A23L29/212 (EP,US); A23L29/25 (EP,US);
A61K9/0007 (EP,US); A61K9/06 (EP,US); A61K9/14 (US);
A61K9/141 (US); A61K9/146 (US); A61P1/00 (EP);
A61P1/16 (EP) (-)
Former IPC [2010/27]A61K9/06, A23K1/16, A61K47/04, A61K47/32, A61K47/36, A61K47/38, A23L1/03, A23L1/053
Former IPC [2007/09]A61K9/06, A23K1/16, A61K47/04, A61K47/32, A61K47/36, A61K47/38
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2017/27]
Former [2007/09]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  MC,  NL,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
TitleGerman:ZUSAMMENSETZUNG IN TROCKENER FORM ZUR ORALEN EINNAHME UND ZUSAMMENSETZUNG IN GELFORM ZUR ORALEN EINNAHME, DIE ZUM ZEITPUNKT DER VERWENDUNG BEREITET WIRD[2007/09]
English:DRY-FORM COMPOSITION FOR ORAL INGESTION AND GEL-FORM COMPOSITION FOR ORAL INGESTION OF TYPE PREPARED AT TIME OF USE[2007/09]
French:COMPOSITION SOUS FORME SÈCHE POUR INGESTION ORALE ET COMPOSITION SOUS FORME DE GEL POUR INGESTION ORALE DE TYPE COMPOSITION PRÉPARÉE AU MOMENT DE L'UTILISATION[2007/09]
Entry into regional phase18.12.2006Translation filed 
18.12.2006National basic fee paid 
18.12.2006Search fee paid 
18.12.2006Designation fee(s) paid 
18.12.2006Examination fee paid 
Examination procedure18.12.2006Examination requested  [2007/09]
30.07.2010Despatch of a communication from the examining division (Time limit: M04)
07.12.2010Reply to a communication from the examining division
30.07.2012Despatch of a communication from the examining division (Time limit: M06)
29.01.2013Reply to a communication from the examining division
04.09.2014Despatch of a communication from the examining division (Time limit: M06)
10.03.2015Reply to a communication from the examining division
21.04.2016Despatch of a communication from the examining division (Time limit: M04)
22.08.2016Reply to a communication from the examining division
14.12.2016Communication of intention to grant the patent
10.04.2017Fee for grant paid
10.04.2017Fee for publishing/printing paid
10.04.2017Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  30.07.2010
Opposition(s)06.04.2018No opposition filed within time limit [2018/24]
Fees paidRenewal fee
23.05.2007Renewal fee patent year 03
26.03.2008Renewal fee patent year 04
26.05.2009Renewal fee patent year 05
24.03.2010Renewal fee patent year 06
24.05.2011Renewal fee patent year 07
29.03.2012Renewal fee patent year 08
16.05.2013Renewal fee patent year 09
25.03.2014Renewal fee patent year 10
22.05.2015Renewal fee patent year 11
30.03.2016Renewal fee patent year 12
23.05.2017Renewal fee patent year 13
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU23.05.2005
AT05.07.2017
CY05.07.2017
CZ05.07.2017
DK05.07.2017
EE05.07.2017
ES05.07.2017
FI05.07.2017
IT05.07.2017
LT05.07.2017
MC05.07.2017
NL05.07.2017
PL05.07.2017
PT05.07.2017
RO05.07.2017
SE05.07.2017
SI05.07.2017
SK05.07.2017
TR05.07.2017
BG05.10.2017
GR06.10.2017
IS05.11.2017
[2020/31]
Former [2020/27]HU23.05.2005
AT05.07.2017
CZ05.07.2017
DK05.07.2017
EE05.07.2017
ES05.07.2017
FI05.07.2017
IT05.07.2017
LT05.07.2017
MC05.07.2017
NL05.07.2017
PL05.07.2017
PT05.07.2017
RO05.07.2017
SE05.07.2017
SI05.07.2017
SK05.07.2017
TR05.07.2017
BG05.10.2017
GR06.10.2017
IS05.11.2017
Former [2020/15]AT05.07.2017
CZ05.07.2017
DK05.07.2017
EE05.07.2017
ES05.07.2017
FI05.07.2017
IT05.07.2017
LT05.07.2017
MC05.07.2017
NL05.07.2017
PL05.07.2017
RO05.07.2017
SE05.07.2017
SI05.07.2017
SK05.07.2017
TR05.07.2017
BG05.10.2017
GR06.10.2017
IS05.11.2017
Former [2019/06]AT05.07.2017
CZ05.07.2017
DK05.07.2017
EE05.07.2017
ES05.07.2017
FI05.07.2017
IT05.07.2017
LT05.07.2017
MC05.07.2017
NL05.07.2017
PL05.07.2017
RO05.07.2017
SE05.07.2017
SI05.07.2017
SK05.07.2017
BG05.10.2017
GR06.10.2017
IS05.11.2017
Former [2018/40]AT05.07.2017
CZ05.07.2017
DK05.07.2017
EE05.07.2017
ES05.07.2017
FI05.07.2017
IT05.07.2017
LT05.07.2017
NL05.07.2017
PL05.07.2017
RO05.07.2017
SE05.07.2017
SI05.07.2017
SK05.07.2017
BG05.10.2017
GR06.10.2017
IS05.11.2017
Former [2018/24]AT05.07.2017
CZ05.07.2017
DK05.07.2017
EE05.07.2017
ES05.07.2017
FI05.07.2017
IT05.07.2017
LT05.07.2017
NL05.07.2017
PL05.07.2017
RO05.07.2017
SE05.07.2017
SK05.07.2017
BG05.10.2017
GR06.10.2017
IS05.11.2017
Former [2018/23]AT05.07.2017
CZ05.07.2017
DK05.07.2017
EE05.07.2017
ES05.07.2017
FI05.07.2017
LT05.07.2017
NL05.07.2017
PL05.07.2017
RO05.07.2017
SE05.07.2017
SK05.07.2017
BG05.10.2017
GR06.10.2017
IS05.11.2017
Former [2018/21]AT05.07.2017
CZ05.07.2017
DK05.07.2017
ES05.07.2017
FI05.07.2017
LT05.07.2017
NL05.07.2017
PL05.07.2017
SE05.07.2017
BG05.10.2017
GR06.10.2017
IS05.11.2017
Former [2018/11]AT05.07.2017
ES05.07.2017
FI05.07.2017
LT05.07.2017
NL05.07.2017
PL05.07.2017
SE05.07.2017
BG05.10.2017
GR06.10.2017
IS05.11.2017
Former [2018/10]AT05.07.2017
FI05.07.2017
LT05.07.2017
NL05.07.2017
SE05.07.2017
Former [2018/09]FI05.07.2017
LT05.07.2017
NL05.07.2017
SE05.07.2017
Former [2018/08]FI05.07.2017
LT05.07.2017
NL05.07.2017
Former [2018/07]LT05.07.2017
Documents cited:Search[X]US5292518  (KUHRTS ERIC H [US]) [X] 1-4,8 * abstract * * column 3, lines 47-59 * * column 4, lines 45-61 * * column 6, lines 9-28 * * example - *;
 [X]DE19859231  (BAUER KURT HEINZ [DE]) [X] 1-4,8 * column 2, lines 40-57 * * abstract * * column 3, lines 39-53 ** column 3, line 65 - column 4, line 1 *
International search[A]JPS6211611B  ;
 [X]JPH0975723  (KOKI BUSSAN KK);
 [X]WO9803260  (KOUKI BUSSAN YUGENKAISHA [JP], et al);
 [A]JPH11322606  (KOBAYASHI SEIYAKU KOGYO KK);
 [A]JP2000103730  (OTSUKA PHARMA CO LTD);
 [A]JP2002104997  (KYORIN SEIYAKU KK);
 [A]JP3522708B
ExaminationUS6299867
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.